(Q43295208)

18 November 2017

title

Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes (English)

1 reference

18 November 2017

Zalan Nemeth

1

1 reference

18 November 2017

Gabor Kokeny

2

1 reference

18 November 2017

Maria Godo

3

1 reference

18 November 2017

Miklós Mózes

4

1 reference

18 November 2017

László Rosivall

5

1 reference

18 November 2017

Marie-Luise Gross

6

1 reference

18 November 2017

Eberhard Ritz

7

1 reference

18 November 2017

Péter Hamar

8

1 reference

18 November 2017

language of work or name

English

0 references

publication date

8 August 2009

1 reference

Nephrology Dialysis Transplantation

18 November 2017

published in

1 reference

18 November 2017

volume

24

1 reference

18 November 2017

issue

12

1 reference

18 November 2017

page(s)

3640-3651

1 reference

Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Effect of aldosterone on renal transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Role of aldosterone in the remnant kidney model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor bl

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Reversal of Glomerulosclerosis after High-Dose Enalapril Treatment in Subtotally Nephrectomized Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Chronic renal failure after nephrotoxic nephritis in rats: contributions to progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(-/-)) after subtotal nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

A comparison of the aldosterone-blocking agents eplerenone and spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP371

21 January 2018

Identifiers

DOI

10.1093/NDT/GFP371

1 reference

18 November 2017

1 reference